E
Medicenna Therapeutics Corp. MDNAF
$0.744 -$0.016-2.11%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings MDNAF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Weak
Risk Grade D-
Reward Grade E
Rating Factors MDNAF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Weak
Efficiency Index Very Weak
Solvency Index Excellent
Total Return Index Fair
Volatility Index Weak
Beta / Standard Deviation MDNAF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Beta 0.86
Price History MDNAF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return 3.98%
30-Day Total Return -14.29%
60-Day Total Return -39.51%
90-Day Total Return -56.24%
Year to Date Total Return -33.27%
1-Year Total Return -35.14%
2-Year Total Return 32.86%
3-Year Total Return -45.69%
5-Year Total Return -54.36%
52-Week High % Change -66.18%
52-Week Low % Change 22.37%
Price MDNAF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $2.20
52-Week Low Price $0.61
52-Week Low Price (Date) Mar 04, 2025
52-Week High Price (Date) Jun 03, 2024
Valuation MDNAF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 58.03M
Enterprise Value 37.16M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.27
Earnings Per Share Growth 65.49%
Price/Earnings To Growth --
Price/Sales (TTM) --
Price/Book (Q) 4.80
Enterprise Value/Revenue (TTM) --
Price $0.74
Enterprise Value/EBITDA (TTM) -2.73
Enterprise Value/EBIT -2.73
Market Cap Category Micro Cap
Dividends and Shares MDNAF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 78.01M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info MDNAF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 416 648 5555
Address 2 Bloor Street West Toronto, ON M4W 3E2
Website www.medicenna.com
Country Canada
Year Founded --
Profitability MDNAF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) --
Profit Margin --
Management Effectiveness MDNAF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -42.57%
Return on Equity --
Income Statement MDNAF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) --
Total Revenue (TTM) --
Revenue Per Share --
Gross Profit (TTM) --
EBITDA (TTM) -13.62M
EBIT (TTM) -13.63M
Net Income (TTM) -19.73M
Net Income Avl. to Common (TTM) -19.73M
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) -1.37%
EPS Diluted (TTM) -0.27
EPS Diluted Growth (Q YOY) 9.52%
Balance Sheet MDNAF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 20.85M
Cash Per Share (Q) $0.27
Total Current Assets (Q) 22.25M
Total Preferred Equity (Q) --
Total Equity (Q) 12.13M
Current Ratio (Q) 10.086
Book Value Per Share (Q) $0.16
Total Assets (Q) 22.41M
Total Current Liabilities (Q) 2.21M
Total Debt (Q) 120.90K
Total Liabilities (Q) 10.28M
Total Common Equity (Q) 12.13M
Cash Flow MDNAF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) -24.20K
Cash from Financing (TTM) 17.15M
Net Change in Cash (TTM) 5.96M
Levered Free Cash Flow (TTM) -8.36M
Cash from Operations (TTM) -11.95M
Weiss Ratings